Hospital.Help

Dresden – In Dresden, research will be conducted into linking artificial intelligence (AI) and biomedicine. The project is being developed as part of a collaboration between the Boehringer Ingelheim Foundation, the Max Planck Society and the TU Dresden, as the Saxon State Chancellery announced. Representatives of the participating institutions signed the contract to set up a corresponding research program in Dresden today.

“BioAI Dresden” aims to contribute to a new scientific understanding of human health. It combines AI methods with biochemical and physical knowledge. The center will be a new international beacon of science, said Prime Minister Michael Kretschmer at the signing ceremony.

“In the life sciences, through the development of measurement methodology, we have come to collect endless amounts of data about what happens in our bodies,” said Ursula Staudinger, Rector of the Technical University of Dresden. We are now faced with the challenge of deciphering this with the help of artificial intelligence and machine learning. This is exactly what the new department will work on.

The new area with two research groups is being created at the Center for Systems Biology Dresden (CSBD), an interinstitutional center between the Max Planck Institutes for Molecular Cell Biology and Genetics and for Physics of Complex Systems and the Technical University of Dresden.

The Boehringer Ingelheim Foundation is funding half of the project with 20 million euros over a period of ten years. The Max Planck Society, the TU Dresden and the Free State of Saxony finance the other half. © dpa/aerzteblatt.de